title: Myocardial infarction after ultrasoundguided foam sclerotherapy for varicose veins--a case report and review of the literature of a rare but serious adverse event.
authors.affiliation: 1 Division of Angiology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.|4 Division of Angiology, Cantonal Hospital Fribourg, Switzerland.
authors.forename: Rolf Peter
authors.initials: RP
authors.lastname: Engelberger
authors.affiliation: 1 Division of Angiology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
authors.forename: Barbara
authors.initials: B
authors.lastname: Ney
authors.affiliation: 2 Division of Cardiology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
authors.forename: Mathieu
authors.initials: M
authors.lastname: Clair
authors.affiliation: 1 Division of Angiology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.|5 Private Practice in Vascular Medicine, Epalinges, Switzerland.
authors.forename: Amin
authors.initials: A
authors.lastname: Dabiri
authors.affiliation: 1 Division of Angiology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
authors.forename: Adriano
authors.initials: A
authors.lastname: Alatri
authors.affiliation: 1 Division of Angiology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
authors.forename: Lucia
authors.initials: L
authors.lastname: Mazzolai
authors.affiliation: 1 Division of Angiology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.|3 Private Practice in Vascular Medicine, Vevey, Switzerland.
authors.forename: Philippe
authors.initials: P
authors.lastname: Kern
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000009:adverse effects*; D015911:Sclerotherapy / Q000009:adverse effects*; D016896:Treatment Outcome; D018084:Ultrasonography, Interventional; D014648:Varicose Veins / Q000175:diagnosis / Q000628:therapy*
chemical_list: D000925:Anticoagulants; D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols